Table of Content
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Insulin Pen Market
6. Market Share
6.1 By Products
6.2 By Disease Types
6.3 By Distribution Channels
6.4 By Country
7. Product
7.1 Disposable Insulin Pen
7.2 Reusable Insulin Pen
8. Disease Types
8.1 Type 1 Diabetes
8.2 Type 2 Diabetes
9. Distribution Channels
9.1 Hospital Pharmacies
9.2 Retail Pharmacies
9.3 E-commerce
10. Countries
10.1 North America
10.1.1 United States
10.1.2 Canada
10.2 Europe
10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey
10.3 Asia Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Thailand
10.3.6 Malaysia
10.3.7 Indonesia
10.3.8 Australia
10.3.9 New Zealand
10.4 Latin America
10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina
10.5 Middle East & Africa
10.5.1 Saudi Arabia
10.5.2 United Arab Emirates
10.5.3 South Africa
11. Porters Five Forces
11.1 Bargaining Power of Buyer
11.2 Bargaining Power of Supplier
11.3 Threat of New Entrants
11.4 Rivalry among Existing Competitors
11.5 Threat of Substitute Products
12. SWOT Analysis
12.1 Strengths
12.2 Weaknesses
12.3 Opportunities
12.4 Threats
13. Reimbursement Policies
14. Company Analysis
14.1 B. Braun Melsungen AG
14.1.1 Overview
14.1.2 Key Persons
14.1.3 Product Analysis
14.1.4 Recent Development
14.1.5 Revenue
14.2 Eli Lilly and Company
14.2.1 Overview
14.2.2 Key Persons
14.2.3 Product Analysis
14.2.4 Recent Development
14.2.5 Revenue
14.3 Becton, Dickinson(BD)
14.3.1 Overview
14.3.2 Key Persons
14.3.3 Product Analysis
14.3.4 Recent Development
14.3.5 Revenue
14.4 Novo Nordisk A/S
14.4.1 Overview
14.4.2 Key Persons
14.4.3 Product Analysis
14.4.4 Recent Development
14.4.5 Revenue
14.5 Ypsomed AG
14.5.1 Overview
14.5.2 Key Persons
14.5.3 Product Analysis
14.5.4 Recent Development
14.5.5 Revenue
14.6 Terumo Corporation
14.6.1 Overview
14.6.2 Key Persons
14.6.3 Product Analysis
14.6.4 Recent Development
14.6.5 Revenue
14.7 Sanofi
14.7.1 Overview
14.7.2 Key Persons
14.7.3 Product Analysis
14.7.4 Recent Development
14.7.5 Revenue
14.8 Julphar
14.8.1 Overview
14.8.2 Key Persons
14.8.3 Product Analysis
14.8.4 Recent Development
14.8.5 Revenue